A Potential Diagnostic and Screening Aid in Alzheimer's Disease
In patients with Alzheimer's disease, plasma p-tau181/Aβ1–42 ratio predicts amyloid status as well as cognitive decline.
Source: medscape.com
Stay updated with breaking news from Erik Stoops. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients with Alzheimer's disease, plasma p-tau181/Aβ1–42 ratio predicts amyloid status as well as cognitive decline.